These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 4903048)

  • 41. ["Haven-gel"--a new local agent for the prevention and therapy of varicose veins].
    Friderich H
    Med Welt; 1968 Nov; 46():2548-50. PubMed ID: 4183340
    [No Abstract]   [Full Text] [Related]  

  • 42. [Gynecological use of a phlebokinetic drug with special reference to its combination with oral contraceptives].
    Cazzola D
    Clin Ter; 1975 Sep; 74(6):559-78. PubMed ID: 1222524
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Hemodynamic action of a drug combination on the venous circulation].
    Bartolo M; Gambelli G
    Clin Ter; 1975 Apr; 73(2):139-46. PubMed ID: 1220883
    [No Abstract]   [Full Text] [Related]  

  • 44. [Initial results of therapy with Sigma-Elmedal].
    Gniwotta E; Schäfer HJ
    Z Allgemeinmed; 1972 Feb; 48(5):238-9. PubMed ID: 4553931
    [No Abstract]   [Full Text] [Related]  

  • 45. [Therapeutic experiences with Vasoforte].
    Schrüffer H
    Z Allgemeinmed; 1973 Aug; 49(23):1103-5. PubMed ID: 4731530
    [No Abstract]   [Full Text] [Related]  

  • 46. [Therapy of varicose veins, thrombophlebitis and thromboembolism with solvosal].
    Naegele M
    Med Welt; 1969 Oct; 43():2384-8. PubMed ID: 5385837
    [No Abstract]   [Full Text] [Related]  

  • 47. [Treatment of circulatory venous diseases: double-blind study with Sandovene].
    Lambelet F
    Schweiz Rundsch Med Prax; 1973 Jul; 62(29):925-9. PubMed ID: 4198273
    [No Abstract]   [Full Text] [Related]  

  • 48. [Clinical experience with a new compound with vasodynamic and capillaroprotective action in the treatment of venous diseases of the lower limbs].
    Bagliani A; Vittori F
    Minerva Cardioangiol; 1972; 20(7):390-6. PubMed ID: 5050746
    [No Abstract]   [Full Text] [Related]  

  • 49. [Clinical test of the new antivaricose agent BayroVas].
    Berger H; Derra A
    Med Welt; 1972 Apr; 23(15):560-3. PubMed ID: 4402616
    [No Abstract]   [Full Text] [Related]  

  • 50. [Results of our experience in the use of mesoglycan in the therapy of acute and chronic venous diseases of the legs].
    Mangoni N; Righi D; Lucente E; Tonarelli AP; Lucarelli F; Borgioli F; Nuzzaci G
    Minerva Med; 1986 Oct; 77(41):1903-8. PubMed ID: 2946983
    [No Abstract]   [Full Text] [Related]  

  • 51. [Therapeutic effects of Reparil. Clinical experimental studies and therapeutic observations].
    Steinacher J
    Z Haut Geschlechtskr; 1972 Jul; 47(13):559-64. PubMed ID: 4569258
    [No Abstract]   [Full Text] [Related]  

  • 52. [Possibilities of a complex etiologic therapy of veinous diseases].
    Kumpmann U
    Z Allgemeinmed; 1969 Oct; 45(28):1327-31. PubMed ID: 5386120
    [No Abstract]   [Full Text] [Related]  

  • 53. [Clinical research on the therapeutic action of mucopolysaccharides of vascular origin in cutaneous vascular pathology].
    Giacometti C; Marpillero P
    G Ital Dermatol Minerva Dermatol; 1971 May; 46(5):231-5. PubMed ID: 4254211
    [No Abstract]   [Full Text] [Related]  

  • 54. [Glyvenol--an integral venodynamic drug].
    Heynen U
    Z Allgemeinmed; 1972 Feb; 48(4):193-5. PubMed ID: 4552448
    [No Abstract]   [Full Text] [Related]  

  • 55. [Effectiveness of the use of chorionic gonadotropin in arteriopathies, phlebopathies and hepatic failure].
    De Pergola E; De Pergola G
    Minerva Med; 1978 Apr; 69(21):1455-61. PubMed ID: 683549
    [No Abstract]   [Full Text] [Related]  

  • 56. [Strophanthin-convallatoxol. Clinical comparative double-blind trial].
    Baumgarten G; Beickert A; Berdrow J; Fiehring H; Förster W; Haak W; Hafemeister R; Kiesewetter R; Klein KW; Knappe J; von Knorre G; Krosch H; Lehmann L; Mann D; Menzel B; Noack W; Rösner R; Sundermann A
    Dtsch Gesundheitsw; 1970 May; 25(20):922-6. PubMed ID: 4942748
    [No Abstract]   [Full Text] [Related]  

  • 57. [Experimentation with a new heparinoid by cutaneous route in medical practice].
    Mamou H
    Sem Hop; 1966 Feb; 42(7):440-2. PubMed ID: 4160020
    [No Abstract]   [Full Text] [Related]  

  • 58. [Clinical studies and therapeutic trials with a new phlebotropic substance].
    Matanic V
    Z Allgemeinmed; 1970 Apr; 46(10):530-4. PubMed ID: 4945230
    [No Abstract]   [Full Text] [Related]  

  • 59. [Medico-legal aspects of medical and surgical treatments in venous pathology].
    Devèze F; Kieffer B
    Phlebologie; 1985; 38(4):621-31. PubMed ID: 4095150
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [On the therapy of skin and veneral diseases. Review of the literature 1965-66].
    Walther H
    Dtsch Med J; 1968 Mar; 19(6):193-8 concl. PubMed ID: 4181102
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.